8 Results for "

C57BL /6J

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "C57BL /6J" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-117427
CAS No.: 1236767-85-3
Purity:  99.90%
Research Areas:  

Metabolic Disease

D5D-IN-326 is a selective, orally active delta-5 desaturase (D5D) inhibitor, with IC50s of 72 and 22 nM for rat and human D5D in enzymic and cell-based assays, respectively, has no effect on D6D or D9D activity. D5D-IN-326 reduces insulin resistance and decreases body weight in diet-induced obese C57BL/6J mice .
loading...
    loading...
Cat. No.: HY-W743888
CAS No.: 65527-61-9
Synonyms: 6-Allyl-6-nor-LSD
Research Areas:  

Neurological Disease

AL-LAD is a 5-HT2A receptor ligand with rat Ki values of 8.1 nM and 3.4 nM. AL-LAD mediates behavioral responses characteristic of serotonergic psychedelics. AL-LAD induces the head-twitch response in male C57BL/6J mice in an inverted-U-shaped dose-dependent manner. AL-LAD exhibits LSD-like behavioral effects in male C57BL/6J mice .
loading...
    loading...
Cat. No.: HY-128435
CAS No.: 606-12-2
Target:  

Estrogen Receptor/ERR

Research Areas:  

Metabolic Disease

2,4'-Dihydroxybenzophenone ((Z)-SU4312) exhibited estrogenic activities. 2,4'-Dihydroxybenzophenone has oral bioactivity that can effectively protect C57BL/6J mice from Acetaminophen (HY-66005, APAP)-induced hepatotoxicity .
loading...
    loading...
Cat. No.: HY-144743
CAS No.: 2771312-16-2
Research Areas:  

Others

ATX inhibitor 12 (compound 20) is an orally active and potent ATX (autotaxin) inhibitor, with an IC50 of 1.72 nM. ATX inhibitor 12 effectively alleviates lung structural damage with fewer fibrotic lesions at an oral dose of 60 mg/kg in C57Bl/6J mice. ATX inhibitor 12 can be uesd for idiopathic pulmonary fibrosis (IPF) research .
loading...
    loading...
Cat. No.: HY-157429
CAS No.: 2865185-31-3
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

25N-N1-Nap (compound 16) is a β-arrestin-biased 5-HT2A agonist. 25N-N1-Nap antagonizes phencyclidine induced hyperactivity in Male C57BL/6 J mice .
loading...
    loading...
Cat. No.: HY-W887123
CAS No.: 69113-01-5
Target:  

Others

Research Areas:  

Cancer

N-nitroso-tris-chloroethylurea (NTCU) can be used for chemically inducing a lung squamous cell carcinoma model. Lung squamous cell carcinoma can be induced in five mouse strains (SWR/J, NIH Swiss, A/J, BALB/cJ, and FVB/J) by applying N-nitroso-tris-chloroethylurea to the skin, but not in the other three strains (AKR/J, 129/svJ, and C57BL/6J) .
loading...
    loading...
Cat. No.: HY-173309
P53/TLR2 modulator-1 (Compound Z9) is a modulator that targets both the P53 pathway and TLR2 simultaneously, exhibiting anti-radiation activity. P53/TLR2 modulator-1 reduces apoptosis by inhibiting the radiation-induced expression of P53 and Bax. At the same time, it activates the TLR2 pathway, upregulates the expression of downstream proteins MyD88 and P65, and promotes the secretion of cytokines such as IL-6, thus exerting an anti-radiation effect. P53/TLR2 modulator-1 shows significant anti-radiation activity against both AHH-1 cells and HUVECs. It can also increase the survival rate of C57BL/6J mice irradiated with a lethal dose of radiation and reduce the damage to their hematopoietic system, the villous structure of the small intestine, and the spleen caused by radiation. P53/TLR2 modulator-1 can be used in the research of radiation injury-related diseases .
loading...
    loading...
Cat. No.: HY-184931
Research Areas:  

Cancer

PTPN22-IN-3 is a potent, selective, and orally active inhibitor of PTPN22 with an IC50 of 0.49 μM and a Ki of 0.28 μM. PTPN22-IN-3 exhibits over 14-fold selectivity against a broad panel of PTPs and shows no significant inhibition against SRC/CSK kinases or IDO1/Arginase metalloenzymes. PTPN22-IN-3 enhances TCR signaling, increases IL-2 expression and secretion, and promotes mouse splenic T cell proliferation. In immune-competent C57BL/6J mice, PTPN22-IN-3 suppresses MC38 syngeneic tumor growth and synergizes with Pembrolizumab (anti-PD-1) (HY-P9902A) therapy. PTPN22-IN-3 can be used for the study of colorectal cancer and other solid tumors responsive to T cell-mediated anti-tumor immunity .
loading...
    loading...